Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Colorectal Neoplasms 20 Rectal Neoplasms 18 Colonic Neoplasms 18 Stomach Neoplasms 13 Ovarian Neoplasms 9 Neoplasms 5 Gastrointestinal Stromal Tumors 5 Carcinoma, Hepatocellular 5 Endometrial Neoplasms 4 Carcinoma, Renal Cell 4 Uterine Cervical Neoplasms 3 Peritoneal Neoplasms 3 Pancreatic Neoplasms 3 Liver Neoplasms 3 Kidney Neoplasms 3 Prostatic Neoplasms 2 Neoplastic Cells, Circulating 2 Fallopian Tube Neoplasms 2 Esophageal Squamous Cell Carcinoma 2 Esophageal Neoplasms 2 Carcinoma, Ovarian Epithelial 2 Venous Thrombosis 1 Uterine Neoplasms 1 Urinary Incontinence 1 Surgical Wound Infection 1 Sexual Dysfunction, Physiological 1 Robotic 1 Polycystic Ovary Syndrome 1 Pancreatic Neuroendocrine Tumors 1 Ovarian Cysts 1

Interventions

pembrolizumab 91 Gemcitabine 56 Nivolumab 50 Cisplatin 39 atezolizumab 37 Carboplatin 30 avelumab 29 enfortumab vedotin 25 Docetaxel 23 Magnetic Resonance Spectroscopy 19 Mitomycin 17 Ipilimumab 17 Paclitaxel 16 Specimen Handling 14 durvalumab 11 toripalimab 10 sacituzumab govitecan 10 Pemetrexed 10 cabozantinib 9 Taxes 8 vinflunine 7 Cyclophosphamide 7 tislelizumab 6 Injections 6 Bevacizumab 6 pemigatinib 5 fludarabine 5 disitamab vedotin 5 Standard of Care 5 Radiosurgery 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Carcinoma, Transitional Cell × Laparoscopy × Clear all

NCT03677544 2023-05-17

CYSTECTOMEN

Centre Hospitalier Universitaire, Amiens

Carcinoma, Transitional Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡